Role of myofibrillogenesis regulator-1 in myocardial hypertrophy

Myofibrillogenesis regulator-1 (MR-1) is a novel homologous gene, identified from a human skeletal muscle cDNA library, that interacts with contractile proteins and exists in human myocardial myofibrils. The present study investigated MR-1 protein expression in hypertrophied myocardium and MR-1 involvement in cardiac hypertrophy. Cardiac hypertrophy was induced by abdominal aortic stenosis (AAS) in Sprague-Dawley rats. Left ventricular (LV) hypertrophy was assessed by the ratio of LV wet weight to whole heart weight (LV/HW) or LV weight to body weight (LV/BW). Rat MR-1 (rMR-1) expression in the myocardium was detected by immunohistochemical and Western blotting analysis. Hypertrophy was induced by ANG II incubation in cultured neonatal rat cardiomyocytes. The effect of rMR-1 RNA interference on ANG II-induced hypertrophy was studied by transfection of cardiomyocytes with an RNA interference plasmid, pSi-1, which targets rMR-1. Hypertrophy in cardiomyocytes was assessed by [3H]Leu incorporation and myocyte size. rMR-1 protein expression in cardiomyocytes was detected by Western blotting. We found that AAS resulted in a significant increase in LV/HW and LV/BW: 89% and 86%, respectively (P < 0.01). Immunohistochemistry and Western blot analysis demonstrated upregulated rMR-1 protein expression in hypertrophic myocardium. ANG II induced a 24% increase in [3H]Leu incorporation and a 65.8% increase in cell size compared with control cardiomyocytes (P < 0.01), which was prevented by treatment with losartan, an angiotensin (AT1) receptor inhibitor, or transfection with pSi-1. rMR-1 expression increased in ANG II-induced hypertrophied cardiomyocytes, and pSi-1 transfection abolished the upregulation. These findings suggest that MR-1 is associated with cardiac hypertrophy in rats in vivo and in vitro.     

Characterization of the amicetin biosynthesis gene cluster from Streptomyces vinaceusdrappus NRRL 2363 implicates two alternative strategies for amide bond formation

Amicetin, an antibacterial and antiviral agent, belongs to a group of disaccharide nucleoside antibiotics featuring an α-(1→4)-glycoside bond in the disaccharide moiety. In this study, the amicetin biosynthesis gene cluster was cloned from Streptomyces vinaceusdrappus NRRL 2363 and localized on a 37-kb contiguous DNA region. Heterologous expression of the amicetin biosynthesis gene cluster in Streptomyces lividans TK64 resulted in the production of amicetin and its analogues, thereby confirming the identity of the ami gene cluster. In silico sequence analysis revealed that 21 genes were putatively involved in amicetin biosynthesis, including 3 for regulation and transportation, 10 for disaccharide biosynthesis, and 8 for the formation of the amicetin skeleton by the linkage of cytosine, p-aminobenzoic acid (PABA), and the terminal (+)-α-methylserine moieties. The inactivation of the benzoate coenzyme A (benzoate-CoA) ligase gene amiL and the N-acetyltransferase gene amiF led to two mutants that accumulated the same two compounds, cytosamine and 4-acetamido-3-hydroxybenzoic acid. These data indicated that AmiF functioned as an amide synthethase to link cytosine and PABA. The inactivation of amiR, encoding an acyl-CoA-acyl carrier protein transacylase, resulted in the production of plicacetin and norplicacetin, indicating AmiR to be responsible for attachment of the terminal methylserine moiety to form another amide bond. These findings implicated two alternative strategies for amide bond formation in amicetin biosynthesis.     

Effect of TGF-β/Smad signaling on sertoli cell and possible mechanism related to complete sertoli cell-only syndrome

Chicken Riboflavin Carrier Protein (cRCP) transports riboflavin from the maternal circulation to the egg yolk for fetal development. The cRCP is a globular protein and structurally very stable due to the presence of nine intra-molecular disulphide bonds. The cRCP comprises of two domains; the larger riboflavin binding, and the smaller, oocyte receptor binding domain. With the objective to study domain folding in cRCP, these two domains of the corresponding gene were amplified, cloned, and expressed in a eukaryotic expression system to obtain soluble product. Our studies on the biochemical characterization of the recombinant proteins indicated that though the ligand binding domain assumed near-native conformation, as determined by immunological methods, it did not bind riboflavin, suggesting the interdependence of the two domains for proper organization of the riboflavin binding pocket.     

Design,synthesis, biological evaluation,and molecular modeling studies of chalcone-rivastigmine hybrids as cholinesterase inhibitors

A series of novel chalcone-rivastigmine hybrids were designed, synthesized, and tested in vitro for their ability to inhibit human acetylcholinesterase and butyrylcholinesterase. Most of the target compounds showed hBChE selective activity in the micro- and submicromolar ranges. The most potent compound 3 exhibited comparable IC₅₀ to the commercially available drug (rivastigmine). To better understand their structure activity relationships (SAR) and mechanisms of enzyme-inhibitor interactions, kinetic and molecular modeling studies including molecular docking and molecular dynamics (MD) simulations were carried out. Furthermore, compound 3 blocks the formation of reactive oxygen species (ROS) in SH-SY5Y cells and shows the required druggability and low cytotoxicity, suggesting this hybrid is a promising multifunctional drug candidate for Alzheimer’s disease (AD) treatment.     

转座子Tn5096对刺孢吸水链霉菌北京变种RF220转座的诱变

用大肠杆菌/链霉菌穿梭质粒pCZA168(bla,tsr,Tn5096,ColEI rep,Strep repts)多次转化农抗120产生菌刺孢吸水链霉菌北京变种(S.Streptomyces hygrospinocus var. beijingensis)RF220的原生质体,均未得到转化子。来自吸水链霉菌应城变种(S.Streptomyces hygroscopicus var.)10-22突变株的链霉菌质粒pIJ702(tsr mel+)可以转化RF220,但转化频率只有数十个转化子/μgDNA。用来自RF220本身的pIJ702对消除pIJ702后的RF220的原生质体进行了再转化,转化率没有明显的提高。用氨苄青霉素和甘氨酸协同处理RF220的菌丝体,并经-70℃冷冻原生质体再转化,得到了4个pCZA168的转化子。质粒提取、酶切、抗性测定表明：4个转化子中pCZA168中大肠杆菌DNA部分均被切除,成为大小约50～60kb的小质粒,命名为pWZH102(tsr,Tn5096,strep repts)。用pWZH102上的转座子Tn5096对RF220进行转座实验,在168个转座个体中,有2株可能为抗生素生物合成阻断变株,另有产生抗生素水平各异的变株,说明Tn5096的转座可以引起表型的不同变化。     

Chemistry and weak antimicrobial activities of phomopsins produced by mangrove endophytic fungus Phomopsis sp. ZSU-H76

Three metabolites named phomopsin A (1), B (2) and C (3), together with two known compounds cytosporone B (4) and C (5), were isolated from the mangrove endophytic fungus, Phomopsis sp. ZSU-H76 obtained from the South China Sea. Their structures were elucidated by spectroscopic methods, mainly by 1D and 2D NMR spectroscopic techniques. The medium-sized cyclic phenol ether based on 1 or 2 is rare in natural products. In bioassays, compounds 1, 2, and 3 had no significant antibiotic activities, but compounds 4 and 5 inhibited two fungi Candida albicans and Fusarium oxysporum with an MIC ranging from 32 to 64 microg/ml.     

硇洲岛海胆可培养细菌的多样性

摘要：【目的】研究南海硇洲岛马粪海胆（Hemicentrotus pulcherrimus）可培养细菌多样性。【方法】采用纯培养法和基于16S rRNA基因序列的系统发育分析对样品中细菌（含放线菌）多样性进行研究。【结果】用补充0～2.0 mol/L NaCl的MA、ISP 2、NA、SWA和HAA培养基从海胆样品中分离到106株细菌菌株,根据形态观察和部分生理生化实验结果去冗余,选取34个代表性菌株进行基于16S rRNA基因序列的系统发育多样性分析。结果表明,这些分离菌株代表21个物种,属于3个大的系     

大连渤海老虎滩海域沉积物可培养放线菌的多样性

【目的】研究大连渤海老虎滩海域可培养放线菌的多样性。【方法】利用5种不同的培养基分离、培养海洋沉积物中的放线菌,并用16S rRNA基因序列对部分放线菌株进行系统发育分析。【结果】根据菌落表型共分离到1215株放线菌。选择271株具有代表性的菌株进行16S rRNA分析,结果表明,251株(92.26%)属于放线菌门,覆盖11个科,15个属;其余20株属于厚壁门和变形菌门;有7株为潜在的新种。【结论】大连渤海老虎滩海域的沉积物中存在较为丰富的放线菌和新种资源,这些菌株为将来开发新的微生物代谢产物奠定了基础。     

Complete genome sequence of Bacillus thuringiensis serovar finitimus strain YBT-020

Bacillus thuringiensis is a gram-positive, spore-forming bacterium that forms parasporal crystals at the onset of the sporulation phase of its growth. Here, we report the complete genome sequence of B. thuringiensis serovar finitimus strain YBT-020, whose parasporal crystals consist of Cry26Aa and Cry28Aa crystal proteins and are located between the exosporium and the spore coat and remain adhering to the spore after sporulation.